Boston Telemedicine Company Amwell Prices IPO
PYMNTS
SEPTEMBER 9, 2020
Amwell , the Boston-based telemedicine company, is planning to go public as the demand for virtual healthcare offerings skyrockets amid the coronavirus pandemic. The company has set a price of between $14 and $16 per share for its sale of 35 million shares. The proceeds would raise between $490 million and $560 million.
Let's personalize your content